Precision Reprogramming of Lung Cancer Biomarkers via CRISPR/Cas9: A Paradigm Shift in Personalized Immunotherapy. Journal of Analytical Oncology, [S. l.], v. 14, p. 96–105, 2025. DOI: 10.30683/1927-7229.2025.14.15. Disponível em: https://neoplasiaresearch.com/index.php/jao/article/view/917. Acesso em: 7 may. 2026.